4d Molecular Therapeutics, Inc. · NASDAQ:FDMT

Bizily Scott sold 6,566 4d Molecular Therapeutics, Inc. shares (Form 4)

Traded Jun 30, 2026 · Filed Jul 2, 2026

On Jun 30, 2026, Bizily Scott (Chief Legal Officer) sold 6,566 4d Molecular Therapeutics, Inc. shares at US$14.00 for US$91,924 under a trading plan, leaving 8,617 shares. Filed Jul 2, 2026 (Form 4).

Sold
6,566 shares
Price
US$14.00
Value
US$91,924
Holding after
8,617 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common StockOption exercise814US$4.149,431Direct
Jun 30, 2026Common StockOption exercise5,752US$6.4915,183Direct
Jun 30, 2026Common StockSale6,566US$14.008,617Direct

Source

View original at SEC

Related